@article{article, title = {{2408TiP DISCUS: A randomised phase II study of 3 vs 6 cycles of chemotherapy followed by maintenance avelumab in advanced urothelial cancer - Wearable devices and circulating biomarkers assessing quality of life and surrogate efficacy endpoints}}, publisher = {{Elsevier BV}}, url = {{http://dx.doi.org/10.1016/j.annonc.2023.09.2826 }}, year = {{2023}}, month = {{10}}, author = {{Jackson-Spence F and Marin AP and Puente J and Molina-Cerrillo J and Hussain SA and Ackerman C and Bonsu N and Kelly J and Loriot Y and Powles TB and Pulido EG}}, doi = {{10.1016/j.annonc.2023.09.2826}}, volume = {{34}}, journal = {{Annals of Oncology}}, pages = {{S1224-S1225}}, note = {{Accessed on 2025/04/11}}}